Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis - Health News - redOrbit
Links shared publicly online about this topic.
- 132total visits
Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis - Health News - redOrbit
EASTBOURNE, England, July 20, 2011 /PRNewswire/ -- Daval International announced the completion of the treatment period of its randomised, placebo-controlled, double blind Phase II Study, Treating Patients with Bladder Dysfunction with AIMSPRO in Secondary Progressive Multiple Sclerosis (SPMS).
View full resource at redorbit.com
Tags: Multiple Sclerosis, Blindness, Urinary System, Healthy Living, News, Bladder Dysfunction
Most Recently Shared on July 20, 2011 at 6:39 pm By:
Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO... http://bit.ly/p0QBCJ
Advertisement
